CSASF(CSASF)
CSASF
No analyst ratings available
No analyst price targets available for CSASF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $509.23B | $539.36B | $570.78B | $616.63B | $652.40B |
| Low | $500.56B | $508.17B | $549.08B | $593.19B | $627.61B |
| High | $512.73B | $573.34B | $591.17B | $638.66B | $675.72B |
| EBITDA Avg | $130.36B | $138.08B | $146.12B | $157.86B | $167.01B |
| Low | $128.14B | $130.09B | $140.57B | $151.86B | $160.67B |
| High | $131.26B | $146.77B | $151.34B | $163.50B | $172.98B |
| EBIT Avg | $92.45B | $97.92B | $103.63B | $111.95B | $118.45B |
| Low | $90.88B | $92.26B | $99.69B | $107.70B | $113.94B |
| High | $93.09B | $104.09B | $107.33B | $115.95B | $122.68B |
| Net Income Avg | $496M | $532M | $570M | $617M | $671M |
| Low | $471M | $505M | $542M | $586M | $638M |
| High | $519M | $556M | $596M | $645M | $703M |
| EPS Avg | $542.10 | $581.33 | $623.05 | $674.19 | $734.29 |
| Low | $515.32 | $552.61 | $592.27 | $640.88 | $698.01 |
| High | $567.28 | $608.34 | $652.00 | $705.51 | $768.41 |
| Analysts (Rev / EPS) | 5 / 1 | 7 / 1 | 5 / 1 | 3 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $125.93B | $131.79B | $130.15B |
| Low | $125.53B | $131.37B | $129.74B |
| High | $126.33B | $132.22B | $130.57B |
| EBITDA Avg | $32.24B | $33.74B | $33.32B |
| Low | $32.14B | $33.63B | $33.21B |
| High | $32.34B | $33.85B | $33.42B |
| EBIT Avg | $22.86B | $23.93B | $23.63B |
| Low | $22.79B | $23.85B | $23.55B |
| High | $22.94B | $24.00B | $23.70B |
| Net Income Avg | $18.33B | $19.82B | $16.51B |
| Low | $18.26B | $19.74B | $16.44B |
| High | $18.41B | $19.90B | $16.58B |
| EPS Avg | $127.44 | $137.77 | $114.77 |
| Low | $126.91 | $137.20 | $114.29 |
| High | $127.96 | $138.34 | $115.24 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 |